Standard Therapeutic Company

The treatment of genetic disease is limited by the delivery of genetic medicine.

Target specificity and low immunogenicity dictate success, yet scarce data and institutional bias have trapped researchers and industry in a mediocre local minimum.

Standard Therapeutic Company exists to explore what lies beyond.